| 000 | 01398 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515214233.0 | ||
| 264 | 0 | _c20100624 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1873-5835 | ||
| 024 | 7 |
_a10.1016/j.leukres.2010.02.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIkezoe, Takayuki | |
| 245 | 0 | 0 |
_aSuccessful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib. _h[electronic resource] |
| 260 |
_bLeukemia research _cAug 2010 |
||
| 300 |
_ae200-1 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypereosinophilic Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTogitani, Kazuto | |
| 700 | 1 | _aTasaka, Taizo | |
| 700 | 1 | _aNishioka, Chie | |
| 700 | 1 | _aYokoyama, Akihito | |
| 773 | 0 |
_tLeukemia research _gvol. 34 _gno. 8 _gp. e200-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.leukres.2010.02.024 _zAvailable from publisher's website |
| 999 |
_c19666788 _d19666788 |
||